Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
BioSteel has entered a multi-year partnership with the Philadelphia 76ers, becoming the official sports drink of the team and the presenting partner for the 76ers Training Camp. This agreement includes significant brand visibility at home games and the team’s training complex in Camden, New Jersey, featuring digital signage and product placement. BioSteel's logo will be prominently displayed on various items during games. The partnership emphasizes BioSteel's commitment to providing sugar-free hydration products, aimed at enhancing athlete performance.
Canopy Growth Corporation has published a groundbreaking study on the long-term toxicity and lifespan effects of cannabidiol (CBD) using the preclinical model C. elegans. Conducted in partnership with NemaLife Inc., the study indicates that CBD shows no acute or chronic toxicity at physiological concentrations. Instead, it extends mean lifespan by up to 18% and increases late-stage life activity by 206%. This research, published in the Cannabis and Cannabinoid Research journal, supports ongoing investigations into CBD's potential health benefits and influences public policy regarding cannabis use.
Canopy Growth Corporation (NYSE: CGC) has launched a limited edition Martha Stewart CBD Wellness Gummies Sampler, featuring 60 gummies in 15 seasonal flavors for the holidays. Retailing at $64.99, the sampler will be available for pre-order starting November 11, with shipping set for November 27. The gummies contain 10mg of premium CBD isolate each, crafted to offer wellness benefits while being a luxurious gift option. This collaboration between Canopy Growth and Martha Stewart aims to enhance the CBD product line, appealing to consumers looking for both quality and flavor.
Canopy Growth Corporation (CGC) reported record quarterly net revenue of $135 million for Q2 Fiscal 2021, driven by robust sales in the Canadian recreational market and contributions from acquired brands.
Despite revenue growth, the company faced a net loss of $97 million but improved its Adjusted EBITDA loss to $86 million, a 43% reduction compared to Q2 FY20.
The firm aims to achieve $150-$200 million in cost savings and has seen a 200 basis point market share increase in Canada.
Canopy Growth Corporation will transfer its U.S. stock listing from the New York Stock Exchange to the Nasdaq effective November 13, 2020. This transition aims to enhance cost-effectiveness and improve investor connectivity. Common shares will start trading on Nasdaq under the ticker CGC on November 16, 2020, with no action required from current shareholders. CEO David Klein emphasized the move aligns Canopy with leading innovative companies. The company is known for its diversified cannabis products and has significant partnerships in the industry.
Canopy Growth Corporation (TSX: WEED, NYSE: CGC) will announce its financial results for the second quarter of fiscal 2021, concluding on September 30, 2020, before markets open on November 9, 2020. Following the results, CEO David Klein and CFO Mike Lee will host an audio webcast at 10:00 AM ET. Canopy Growth continues to lead in the cannabis industry with its diversified product offerings and strong brand presence across Canada, including Tweed and Tokyo Smoke.
Canopy Growth Corporation (CGC) and Acreage Holdings have partnered to introduce Canopy's THC beverages in the U.S., starting summer 2021. Acreage aims to leverage its presence in Illinois and California to market these products through both its own dispensaries and existing distribution channels. Canopy has achieved significant success in Canada, selling over 1.7 million cans and holding a 74% market share in the cannabis beverage sector. The collaboration aims to capture growth in the expanding U.S. cannabis market.
Canopy Growth Corporation (NYSE: CGC) and Acreage Holdings, Inc. have executed an amended arrangement under British Columbia law. The arrangement introduces new share classes, allowing for the exchange of existing shares into Fixed and Floating Shares. Trading of these shares begins today on the Canadian Securities Exchange. Canopy Growth will acquire Fixed Shares at a specified exchange rate once U.S. federal marijuana laws permit. Acreage will remain independent while focusing on profitability and expanding its product offerings. Shareholders are set to receive approximately $0.30 per share as part of a $37.5 million upfront payment.
Canopy Growth announced the results from its annual general and special meeting of shareholders held on September 21, 2020. A total of 260,647,934 common shares were voted, representing 70.22% of outstanding shares. All proposed matters, including the election of directors and appointment of KPMG as auditors for fiscal 2021, were approved. Directors Judy A. Schmeling and David Klein received 99.13% and 99.05% approval, respectively. Shareholders also greenlit amendments to the Omnibus Incentive Plan and established annual votes on executive compensation.
Canopy Growth Corporation and Acreage Holdings announced that Acreage received final court approval for an amended arrangement under British Columbia law. The implementation is expected around September 23, 2020. Eligible Acreage shareholders as of September 22 will receive a pro rata share of US$37,500,024, approximately US$0.30 per Subordinate Voting Share. Shareholder approval was granted on September 16, 2020. This arrangement may lead to wider operational collaboration and potential for growth in the cannabis sector.